CorMedix (CRMD) Current Taxes (2025)

CorMedix's (CRMD) quarterly Current Taxes came in at $12.8 million in Q4 2025, up 202.21% quarter-over-quarter from $4.2 million in Q3 2025.

CorMedix (CRMD) Current Taxes (2025) Analysis & Trends

CorMedix has disclosed Current Taxes across 1 years of filings, most recently posting $12.8 million for Q4 2025.

Current Taxes for Q4 2025 came in at $12.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $12.8 million (changed N/A YoY), and the FY2025 annual result was $12.8 million, changed N/A from the prior year.
Current Taxes came in at $12.8 million for Q4 2025 at CorMedix, up from $4.2 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $12.8 million in Q4 2025 to a low of $521507.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	10,460.56
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	19.20 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	CorMedix	631,378.03	-154.57 Mn	107.31 Mn	12.76 Mn

Download Data